Mallinckrodt Announces Appointment of Lisa French as Chief Commercial Officer

DUBLIN, Sept. 19, 2022 /PRNewswire/ -- Mallinckrodt plc (OTCMKTS:MNKPF) ("Mallinckrodt" or the "Company"), a global specialty pharmaceutical company, today announced it has appointed Lisa French as Executive Vice President and Chief Commercial Officer, effective October 1, 2022. Ms. French brings more than 30 years of commercial biopharmaceutical experience and will oversee the development and execution of Mallinckrodt's commercialization strategy. Ms. French will serve on the Executive Committee and succeeds Hugh O'Neill, who departed Mallinckrodt as of September 16, 2022.